Phakic Posterior Chamber Intraocular Lens for High Myopia

CHEN li,MA bo,WANG congyi
DOI: https://doi.org/10.3760/cma.j.issn.1006-4443.2010.04.023
2010-01-01
Abstract:Objective To evaluate the efficacy and safety of the surgical correction of high myopia using a phakic posterior chamber intraocular lens (PCPIOL).Methods Thirty-four eyes of 18 patients with high myopia who accepted surgery treatment.Each eye was examined before and after surgery.The examination included visual acuity,refraction,tonometry,kerameter,pachometer,anterior chamber depth,horizontal corneal diameter (white to white),and posterior segment evaluation after indirect ophthalmolscope examination.All surgeries were performed using topical anesthesia and clear corneal incision.The posterior chamber phakic intraocular lens manufactured with STAAR collamer was implanted between transparent lens and iris.Results All eyes of preoperative uncorrected visual acuity (UCVA) and best-corrected visual acuity (BCVA) were 0.08±0.06,0.5±0.3 respectively and postoperative were 0.5±0.2,0.7±0.2 respectively.The mean preoperative SE was -19.9±5.4D and postoperative SE was -1.5±1.5D.The mean preoperative ECD was 3249.6±337.1/mm~2 and postoperative ECD was 3103.4±305.5/mm~2 and the percentage of loss was 4.5%.The mean preoperative IOP was 15.5±2.7 mmHg and postoperative IOP at first day was 19.4±7.3 mmHg.UBM showed that preoperative ACD was 3.20±0.30 mm and postoperative ACD reduced 2.99±0.19 mm.Conclusions The phakic IOLs were an effective treatment for the correction of high myopia and have significant advantages such as reversibility,immediate correction,stability,and relative simplicity.However,long-term studies are necessary to assess the potential risks.
What problem does this paper attempt to address?